Key statistics
On Wednesday, Crossject SA (ALCJ:PAR) closed at 2.38, 56.25% above the 52 week low of 1.52 set on Jun 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.37 |
---|---|
High | 2.41 |
Low | 2.37 |
Bid | 2.37 |
Offer | 2.39 |
Previous close | 2.35 |
Average volume | 45.72k |
---|---|
Shares outstanding | 41.28m |
Free float | 31.45m |
P/E (TTM) | -- |
Market cap | 97.01m EUR |
EPS (TTM) | -0.2329 EUR |
Data delayed at least 15 minutes, as of Sep 18 2024 16:26 BST.
More ▼
- Crossject to report first-half 2024 financial results and host webcast on September 23, 2024
- Crossject publiera ses résultats financiers du premier semestre et organisera un webcast le 23 Septembre 2024
- Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright, 9 au 11 septembre 2024
- Crossject to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024
- Crossject appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization of ZEPIZURE® Epilepsy Rescue Treatment
- Tony Tipton nommé au poste de directeur des opérations États-Unis de Crossject en vue de la commercialisation de ZEPIZURE®, traitement d'urgence dans la prise en charge des crises d’épilepsie
- Crossject franchit une nouvelle étape clé dans la fabrication de ZEPIZURE®
- Crossject achieves key ZEPIZURE® manufacturing milestone
- Crossject to attend H.C. Wainwright 26th Annual Global Investment Conference
- Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright
More ▼